Aβ-independent processes—rethinking preclinical AD
Author:
- 12 February 2013
- journal article
- research article
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 9 (3) , 123-124
Abstract
The amyloid cascade hypothesis, which posits that amyloid-β accumulation is the key event in Alzheimer disease neurodegeneration, has dominated the field for 20 years. Recent findings, however, show that neuronal-injury biomarkers are independent of amyloid-β, calling for reconsideration of the pathological cascade and assessment of alternative therapeutic strategies.Keywords
This publication has 10 references indexed in Scilit:
- Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal AgingThe Journal of Neuroscience, 2012
- Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control studyThe Lancet Neurology, 2012
- Brain injury biomarkers are not dependent on β‐amyloid in normal elderlyAnnals of Neurology, 2012
- Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease DementiaThe Journal of Neuroscience, 2012
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer diseaseNeurology, 2012
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's diseaseBrain, 2007